$DLB

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d165402dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We co

Original reporting
Published Jul 30, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$DLB
Neutral
medium confidence
Mentioned
$DLB
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DLBNeutralHigh
01

Why it matters

Traders can update models immediately using the disclosed Q4 and FY2026 revenue, licensing revenue, margin, operating expense, tax rate, and EPS ranges, and incorporate the increased buyback authorization and declared dividend into capital return expectations.

02

Market read

The filing combines earnings and explicit guidance with capital return actions, making it a direct input to near-term valuation and positioning for DLB.

03

What to watch

The mix between GAAP and non-GAAP earnings, plus the reliance on royalty-based revenue estimates, could drive larger-than-expected volatility if licensing demand or consumer electronics shipments deviate.

Relevance 7/10Novelty 9/10Timing: after-hours filing on July 30, 2026, with Q4 and FY2026 guidance for immediate positioning

Background

This is an SEC Form 8-K (Item 2.02) with Dolby’s Q3 FY2026 financial results, business highlights, dividend and repurchase updates, and forward guidance for Q4 and full-year FY2026.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby reported Q3 FY2026 results and issued Q4 and full-year guidance, including revenue, margins, and EPS ranges, plus a $350M buyback increase.

Expected impact

Likely two-sided reaction depending on whether investors focus on the Q3 revenue decline and GAAP EPS softness versus the raised buyback and the Q4/full-year EPS ranges.

Evidence & confidence

The filing contains fresh, decision-relevant numbers: Q3 revenue and earnings, dividend and expanded repurchase authorization, and explicit Q4 and FY2026 guidance ranges. The article also flags reduced visibility from macro and trade/geopolitical uncertainty, which can temper confidence in the outlook.

Market effects

Signals demand and royalty/licensing momentum for media and entertainment technology, with Dolby Vision/Atmos adoption cited across TV, mobile, and automotive.

Limited direct regional read-through; primarily US-listed issuer with global content and device partner ecosystem.

Highlights ongoing global distribution partnerships (broadcast, streaming, pay TV) and device support, relevant to worldwide consumer electronics and media platforms.

Counterpoint

Investors may discount the guidance ranges because management explicitly says visibility is greatly reduced by macro, trade restrictions, and geopolitical instability.

Key entities

  • Dolby Laboratories, Inc.

    Reported Q3 FY2026 results, declared a $0.36/share dividend, increased its repurchase authorization by $350M, and provided Q4 and FY2026 guidance.

  • Kevin Yeaman

    CEO quoted on execution against full-year objectives and momentum in growth areas.

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBMed

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

$DLBHighAI 9/10

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.